Description
While inflammatory processes are recognized as central to Alzheimer’s pathogenesis, the specific molecular mechanisms linking neuroinflammation to tau pathology, amyloid aggregation, and neuronal loss remain incompletely characterized. This limits identification of precise therapeutic targets within inflammatory cascades.